(RxWiki News) A naturally occurring brain protein could lead to better treatments for Alzheimer's disease. Scientists have discovered a "molecular chaperone" - a type of protein that responds to disease - and its ability to kill toxic Alzheimer's tangles in the brain.
This molecular chaperone, HspB1, is a protective mechanism that interferes with the chain of events that causes brain damage in Alzheimer's. Amyloid beta peptide starts the process, clumping in the brain and killing neurons. HspB1 inhibits that process, according to the recent study, published in Molecular and Cellular Biology.
"Ask your doctor about new medications for Alzheimer's."
Dr. Anil G. Cashikar, biochemist at Georgia Health Sciences University's Center for Molecular Chaperones and Radiobiology and co-author of the study, also has discovered that deleting HspB1-like genes in mice worsens the symptoms of Alzheimer's.
HspB1's role is to protect brain cells, so if its levels could be increased, the result could be a better treatment for the disease, Dr. Cashikar said.
Scientists want to develop smaller versions of HspB1 that could be inserted into the bloodstream, and also find a way to increase the brain's natural production of the molecular chaperone.
In the brains of people with Alzheimer's, several signs are hallmarks of the disease. Neurofibrillary tangles are fragments of protein within neurons that clog up the cell; neuritic plaques are abnormal clusters of dead and dying brain cells and protein; and senile plaques are areas where the products of dying nerve cells have accumlated.
Amyloid beta peptide plays a major role in these developments in the brain.
